Omeros (OMER) Other Non Operating Income (2010 - 2026)
Omeros (OMER) reported Other Non Operating Income of $73.1 million for Q1 2026, up 112632.31% on a YoY basis from N/an in Q1 2025, and down 45.49% sequentially from $134.2 million in Q4 2025.
Omeros (OMER) Other Non Operating Income (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Other Non Operating Income data on file, last reported at $73.1 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 112632.31% year-over-year to $73.1 million; the trailing twelve-month figure through Mar 2026 stood at $208.1 million (up 452591.3% YoY), and the FY2025 full-year result was -$136.7 million, down 719663.16% from the prior year.
- Other Non Operating Income fell to $73.1 million in Q1 2026, from $134.2 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $134.2 million in Q4 2025 to a low of -$65000.0 in Q1 2025.
- A 5-year average of $26.7 million and a median of $735000.0 in 2022 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income tumbled 99.54% in 2024 and surged 706215.79% in 2025, its largest moves.
- Tracing OMER's Other Non Operating Income over 5 years: stood at $670000.0 in 2022, then jumped by 511.94% to $4.1 million in 2023, then plunged by 99.54% to $19000.0 in 2024, then surged by 706215.79% to $134.2 million in 2025, then slumped by 45.49% to $73.1 million in 2026.
- Business Quant data shows OMER's Other Non Operating Income at $73.1 million in Q1 2026, $134.2 million in Q4 2025, and $800000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.15 Mn |
| Dec 31, 2025 | 134.20 Mn |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | -65,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 4.10 Mn |
| Jun 30, 2022 | 670,000.00 |
| Mar 31, 2022 | 493,000.00 |
| Dec 31, 2021 | 526,000.00 |
| Sep 30, 2021 | 461,000.00 |
| Jun 30, 2021 | 333,000.00 |
| Mar 31, 2021 | 418,000.00 |
| Dec 31, 2020 | -13.65 Mn |
| Sep 30, 2020 | -13.37 Mn |
| Jun 30, 2020 | 364,000.00 |
| Mar 31, 2020 | 549,000.00 |
| Dec 31, 2019 | 292,000.00 |
| Sep 30, 2019 | 353,000.00 |
| Jun 30, 2019 | 415,000.00 |
| Mar 31, 2019 | 494,000.00 |